Muscle wasting in disease: molecular mechanisms and promising therapies.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 58, doi. 10.1038/nrd4467
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2015 AND VI 14 AND IP 1
Results: 24
1
2
Infectious diseases: Two-hit antibody tackles bacteria.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 15, doi. 10.1038/nrd4525
- By:
- Publication type:
- Article
3
A decade of innovation in pharmaceutical R&D: the Chorus model.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 17, doi. 10.1038/nrd4497
- By:
- Publication type:
- Article
4
Anticancer agents: CDK7 inhibition suppresses MYC-dependent cancer.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 16, doi. 10.1038/nrd4513
- By:
- Publication type:
- Article
5
Market watch: Upcoming catalysts in Q1 2015.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 9, doi. 10.1038/nrd4517
- By:
- Publication type:
- Article
6
Targeting the IL-17-T<sub>H</sub>17 pathway.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 11, doi. 10.1038/nrd4518
- By:
- Publication type:
- Article
7
The Innovative Medicines Initiative: an engine for regulatory science.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 1, doi. 10.1038/nrd4520
- By:
- Publication type:
- Article
8
What do drug transporters really do?
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 29, doi. 10.1038/nrd4461
- By:
- Publication type:
- Article
9
Bone disorders: BET inhibitor prevents bone loss.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 16, doi. 10.1038/nrd4515
- By:
- Publication type:
- Article
10
Viral diseases: Bacterial flagellin cures rotavirus.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 16, doi. 10.1038/nrd4512
- By:
- Publication type:
- Article
11
Cancer: Cancer exosomes promote tumorigenesis.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 16, doi. 10.1038/nrd4514
- By:
- Publication type:
- Article
12
Anticancer drugs: Finding the perfect combination.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 13, doi. 10.1038/nrd4524
- By:
- Publication type:
- Article
13
Biologics: Transferrin' bispecific antibodies across the blood-brain barrier.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 14, doi. 10.1038/nrd4522
- By:
- Publication type:
- Article
14
Cardiovascular diseases: Reversing anticoagulants.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 16, doi. 10.1038/nrd4521
- By:
- Publication type:
- Article
15
Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging markets.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 8, doi. 10.1038/nrd4516
- By:
- Publication type:
- Article
16
Anticoagulant antidotes start yielding Phase III promise.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 5, doi. 10.1038/nrd4527
- By:
- Publication type:
- Article
17
Wayne Koff.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 10, doi. 10.1038/nrd4528
- Publication type:
- Article
18
Managing diabetes with nanomedicine: challenges and opportunities.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 45, doi. 10.1038/nrd4477
- By:
- Publication type:
- Article
19
EMA greenlights Novartis' first-in-class IL-17 inhibitor.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 7, doi. 10.1038/nrd4530
- By:
- Publication type:
- Article
20
Gene therapy pushes the US $1 million price barrier.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 7, doi. 10.1038/nrd4532
- By:
- Publication type:
- Article
21
FDA reversal sends mixed message to multiple sclerosis community.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 3, doi. 10.1038/nrd4526
- By:
- Publication type:
- Article
22
Grants4Targets: an open innovation initiative to foster drug discovery collaborations.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 74, doi. 10.1038/nrd3078-c2
- By:
- Publication type:
- Article
23
FDA approves first bispecific.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 7, doi. 10.1038/nrd4531
- By:
- Publication type:
- Article
24
Cancer: mTOR inhibition curbs colorectal cancer.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 14, doi. 10.1038/nrd4523
- By:
- Publication type:
- Article